2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1811975733 M.D.
Verify on CMS →

MICHELE SMADJA-GORDON, M.D.

Endocrinology, Diabetes & Metabolism Physician in ANNAPOLIS, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
405
Medicare Part D claims · 167 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
61%
generic claims · 39% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

MICHELE SMADJA-GORDON, M.D. filed 405 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in ANNAPOLIS, Maryland, prescribing 61% generic.

405
Part D claims, 2023
61%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MICHELE SMADJA-GORDON, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

405 Top 38% higher than 62% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

MICHELE SMADJA-GORDON, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MICHELE SMADJA-GORDON, M.D.?

Quality data not reported

NPI registry status

Active

Issued 01/03/2006

NPI 1811975733

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

405 85% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Maryland

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Maryland providers

Maryland providers

Endocrinology, Diabetes & Metabolism Physician share within Maryland

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Maryland

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MICHELE SMADJA-GORDON, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 116 DEFENSE HWY, ANNAPOLIS, MD, 21401, with a listed phone of (410) 897-9841. NPI 1811975733 was issued on 01/03/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SMADJA-GORDON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 405 prescription claims written by this provider, covering 167 Medicare beneficiaries and totaling roughly $188K in drug spend, split 39% brand-name and 61% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

116 DEFENSE HWY
ANNAPOLIS, MD 21401

Provider Details

NPI 1811975733
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 01/03/2006

Brand vs generic prescribing mix · Above average

MICHELE SMADJA-GORDON, M.D. — brand share 39.0%
Specialty average (est.)

39% brand-name claims vs 61% generic, on 405 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

405
Total Claims
$188K
Total Drug Cost
167
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,114
Total Day Supply
33,267
Brand vs Generic
39% brand / 61% generic
Brand Drug Cost
$180K
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
75.6 years
Avg HCC Risk Score
1.44
Gender Split
64% female / 36% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MICHELE SMADJA-GORDON, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
86
Metformin Hcl
34
Methimazole
25
Synthroid
Levothyroxine Sodium
23
Novolog Flexpen
Insulin Aspart
20
Tresiba Flextouch U-200
Insulin Degludec
17
Alendronate Sodium
14
Glipizide Er
Glipizide
13
Basaglar Kwikpen U-100
"Insulin Glargine
N/A
Nano 2nd Gen Pen Needle
"Pen Needle
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How MICHELE SMADJA-GORDON, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

MICHELE SMADJA-GORDON, M.D.'s 405 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as SMADJA-GORDON.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MICHELE SMADJA-GORDON, M.D.'s specialty?
MICHELE SMADJA-GORDON, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in ANNAPOLIS, Maryland. Credentials: M.D..
How much does MICHELE SMADJA-GORDON, M.D. prescribe under Medicare Part D?
In 2023, MICHELE SMADJA-GORDON, M.D. wrote 405 Medicare Part D claims totaling $188K in drug costs for 167 beneficiaries.
Where is MICHELE SMADJA-GORDON, M.D. located?
MICHELE SMADJA-GORDON, M.D. is located at 116 DEFENSE HWY, ANNAPOLIS, MD, 21401. Phone: (410) 897-9841.
What is MICHELE SMADJA-GORDON, M.D.'s NPI number?
MICHELE SMADJA-GORDON, M.D.'s National Provider Identifier (NPI) is 1811975733, issued on 01/03/2006.
Does MICHELE SMADJA-GORDON, M.D. prescribe more brand-name or generic drugs?
MICHELE SMADJA-GORDON, M.D.'s prescribing is 39% brand-name and 61% generic drugs by claim count, with $180K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does MICHELE SMADJA-GORDON, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MICHELE SMADJA-GORDON, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Methimazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MICHELE SMADJA-GORDON, M.D. accept Medicare?
MICHELE SMADJA-GORDON, M.D. appears in CMS Medicare data with 405 Part D claims and 167 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MICHELE SMADJA-GORDON, M.D.'s credentials?
MICHELE SMADJA-GORDON, M.D.'s NPI is 1811975733 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology